![]() Bicycle Therapeutics Bicycle Therapeutics is a clinical-stage biopharmaceutical company that develops cancer therapies. | SINOVAC SINOVAC is a biopharmaceutical company that has expertise in the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases. | ![]() Alumis Alumis (formerly known as Esker Therapeutics) is a clinical-stage biopharmaceutical company developing oral therapies. | ||
Founding Date | Founding Date 1890 | Founding Date 2009 | Founding Date 2001 | Founding Date 2021 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations ID HQ | Locations Cambridge, GB HQ Cambridge, US | Locations CN HQ | Locations San Francisco, US HQ |
Employees | Employees 1,233 | Employees 305 | Employees 2111% decrease | Employees 107 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.7 b | Valuation ($) N/A | Valuation ($) 652.3 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $72.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $24.1m (FY, 2025) |
Net income | Net income N/A | Net income ($219m) (FY, 2025) | Net income N/A | Net income ($243.3m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 89.4m | Total funding raised N/A | Total funding raised $ 270m |

Bicycle Therapeutics is a clinical-stage biopharmaceutical company that develops cancer therapies.
View companySINOVAC is a biopharmaceutical company that has expertise in the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases.
View company
Alumis (formerly known as Esker Therapeutics) is a clinical-stage biopharmaceutical company developing oral therapies.
View company